ADPT

Adaptive Biotechnologies Corp (ADPT)

US
$ 7.67-6.69%

Price Chart

Key Statistics

Market Cap
$ 1.09B
P/E Ratio
0.00
Revenue (TTM)
$ 178.96M
Volume
1.55M
52W High
$ 9.01
52W Low
$ 2.99
Dividend Yield
0.00%
Beta
1.73

Technicals

50-Day MA
7.7863
200-Day MA
6.1016
52 Week High
9.01
52 Week Low
2.99

About ADPT

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform.

Employees
619
Headquarters
Seattle, WA
CEO
Mr. Chad M. Robins M.B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
PLRZ
Polyrizon Ltd. Ordi...
$ 1.24
389.38
KIDZ
Classover Holdings ...
$ 9.17
71.09
FRGT
Freight Technologie...
$ 1.63
65.52
IBO
IBO (Listing Market...
$ 0.60
50.10
CPS
Cooper-Standard Hol...
$ 20.48
34.56

Top Losers

Symbol/Name
LTP
% Chg
ZCAR
Zoomcar Holdings In...
$ 7.57
-42.54
PDEX
Pro-Dex Inc. Common...
$ 45.86
-31.86
XYZ
Block Inc. Class A ...
$ 46.43
-20.61
NVNI
Nvni Group Limited ...
$ 0.33
-19.68
FUBO
fuboTV Inc. Common ...
$ 2.43
-17.06